Cited by 30Neuroscience and Neural EngineeringRetinal Development and DisordersRetinal Diseases and Treatments

Functional vision in the real-world environment with a second-generation (44-channel) suprachoroidal retinal prosthesis

Open access
Karapanos, Lewis, Abbott, Carla J., Ayton, Lauren N., Kolic, Maria, McGuinness, Myra B., Baglin, Elizabeth K., Titchener, Samuel A., Kvansakul, Jessica +6 more·2021·Translational Vision Science & Technology

Abstract

Purpose: In a clinical trial (NCT03406416) of a second-generation (44-channel) suprachoroidal retinal prosthesis implanted in subjects with late-stage retinitis pigmentosa (RP), we assessed performance in real-world functional visual tasks and emotional well-being. Methods: The Functional Low-Vision Observer Rated Assessment (FLORA) and Impact of Vision Impairment-Very Low Vision (IVI-VLV) instruments were administered to four subjects before implantation and after device fitting. The FLORA contains 13 self-reported and 35 observer-reported items ranked for ease of conducting task (impossible-easy, central tendency given as mode). The IVI-VLV instrument quantified the impact of low vision on daily activities and emotional well-being. Results: Three subjects completed the FLORA for two years after device fitting; the fourth subject ceased participation in the FLORA after fitting for reasons unrelated to the device. For all subjects at each post-fitting visit, the mode ease of task with device ON was better or equal to device OFF. Ease of task improved over the first six months with device ON, then remained stable. Subjects reported improvements in mobility, functional vision, and quality of life with device ON. The IVI-VLV suggested self-assessed vision-related quality of life was not impacted by device implantation or usage. Conclusions: Subjects demonstrated sustained improved ease of task scores with device ON compared to OFF, indicating the device has a positive impact in the real-world setting. Translational Relevance: Our suprachoroidal retinal prosthesis shows potential utility in everyday life, by enabling an increased environmental awareness and improving access to sensory information for people with end-stage RP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1167/tvst.10.10.7

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Existing visual prostheses generally provide an improved ability to localize high-contrast objects and to perform basic orientation and mobility tasks.

    “Existing devices generally provide an improved ability to localize high-contrast objects and to perform basic orientation & mobility tasks (Geruschat et al., 2012; Karapanos et al., 2021).”

    From Towards a <i>Smart Bionic Eye</i> : AI-powered artificial vision for the treatment of incurable blindness (2022) · cites this paper as Karapanos et al., 2021

    The Results (FLORA–Ease of Task Scores) report improved ability to find doorways and locate objects, and the Discussion says the device improved day-to-day orientation and mobility outcomes. But the paper studies one prosthesis, not existing devices generally; its own visual-mobility tasks showed minimal improvement, and it does not establish a general improvement in localizing high-contrast objects. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In practice, FLORA is often employed as an external validation tool that constitutes the very last step of the design process.

    “While it is encouraging to see increasing adoption of FLORA by the community (Geruschat et al., 2016; Karapanos et al., 2021), in practice it is often employed as an external validation tool that constitutes the very last step of the design process—a proof of concept, so to speak.”

    From Towards a <i>Smart Bionic Eye</i> : AI-powered artificial vision for the treatment of incurable blindness (2022) · cites this paper as Karapanos et al., 2021

    The Methods passage and Figure 1 timeline show FLORA used to assess the prosthesis, including an independent specialist’s assessments before implantation and at multiple points after device fitting. This supports its use as an evaluation tool, but not the claim that it is often an external validation tool used only at the very last step of design. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 32 · Cited by 30

Authors
Karapanos, L., Abbott, C. J., Ayton, L. N., Kolic, M., McGuinness, M. B., Baglin, E. K., Titchener, S. A., Kvansakul, J., Johnson, D., Kentler, W. G., Barnes, N., Nayagam, D. A. X., Allen, P. J., & Petoe, M. A.
Affiliations
  • The University of Melbourne (AU)
  • The Royal Victorian Eye & Ear Hospital (AU)
  • Bionics Institute (AU)
  • Specialised Orientation and Mobility, Melbourne, VIC, Australia
  • Australian National University (AU)
Corresponding author
Petoe, Matthew A.
Venue
Translational Vision Science & Technology
Published
2021-08-12
Volume
10
Issue
10
Pages
7
ISSN
2164-2591 (ISSN-L)
OpenAlex
W3188148682
Cited by
30
References
32
Citations by year
2026: 7 · 2025: 7 · 2024: 5 · 2023: 6 · 2022: 5
FWCI
1.84
Type
journal article
Language
en
Open access
Locations
  • Translational Vision Science & Technology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • ANU Open Research (Australian National University) (submittedVersion, cc-by-nc-nd)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
Funders
State Government of Victoria
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neural Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
retinitis pigmentosa, functional vision, flora, quality of life, emotional well-being, mobility (physical function), environmental awareness
MeSH terms
Humans, Quality of Life, Retinitis Pigmentosa, Vision, Ocular, Vision, Low, Visual Prosthesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review